Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
第一作者:
K,Takeda
第一单位:
Department of Pulmonary Medicine, Osaka City General Hospital, Osaka, Japan.
作者:
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);喜树碱(Camptothecin);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);癌, 鳞状细胞(Carcinoma, Squamous Cell);综合疗法(Combined Modality Therapy);剂量效应关系, 药物(Dose-Response Relationship, Drug);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);肿瘤分期(Neoplasm Staging);辐射增敏药(Radiation-Sensitizing Agents);治疗结果(Treatment Outcome)
DOI
10.1038/sj.bjc.6690233
PMID
10188891
发布时间
2018-12-01
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文